1. Home
  2. KPTI
  3. KPTI News

Latest Karyopharm Therapeutics Inc. (KPTI) News on November 24, 2024

KPTI

MT Newswires

4 days ago

Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer
KPTI

PR Newswire

4 days ago

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer

Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
KPTI

PR Newswire

6 days ago

Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
KPTI

Simply Wall St.

16 days ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Karyopharm Therapeutics Third Quarter 2024 Earnings: Beats Expectations
KPTI

Simply Wall St.

18 days ago

Karyopharm Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...
KPTI

GuruFocus.com

18 days ago

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript
KPTI

Motley Fool

19 days ago

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript

Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates
KPTI

Zacks

19 days ago

Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates

KPTI

Associated Press Finance

19 days ago

Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
KPTI

PR Newswire

19 days ago

Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings
KPTI

GuruFocus.com

20 days ago

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

23 days ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline
KPTI

Zacks

23 days ago

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
KPTI

Zacks

24 days ago

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
KPTI

PR Newswire

24 days ago

Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024

Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
KPTI

PR Newswire

24 days ago

Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024
KPTI

PR Newswire

25 days ago

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics Shares
KPTI

GuruFocus.com

a month ago

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics Shares

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

2 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics (KPTI) Looks Ripe for a Turnaround
KPTI

Zacks

3 months ago

Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics (KPTI) Looks Ripe for a Turnaround

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

3 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm to Participate at Upcoming Investor Conferences
KPTI

PR Newswire

3 months ago

Karyopharm to Participate at Upcoming Investor Conferences

Pipeline Moves: Investigator-led oncology cell therapy trial terminated
KPTI

Clinical Trials Arena

3 months ago

Pipeline Moves: Investigator-led oncology cell therapy trial terminated

With 58% ownership, Karyopharm Therapeutics Inc. (NASDAQ:KPTI) boasts of strong institutional backing
KPTI

Simply Wall St.

3 months ago

With 58% ownership, Karyopharm Therapeutics Inc. (NASDAQ:KPTI) boasts of strong institutional backing

KPTI

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Karyopharm Therapeutics Inc Earnings Call

Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
KPTI

Motley Fool

4 months ago

Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript

Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates
KPTI

Zacks

4 months ago

Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates

KPTI

Associated Press Finance

4 months ago

Karyopharm Therapeutics: Q2 Earnings Snapshot

Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
KPTI

PR Newswire

4 months ago

Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

4 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024
KPTI

PR Newswire

4 months ago

Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024

Earnings Preview: Assertio (ASRT) Q2 Earnings Expected to Decline
KPTI

Zacks

4 months ago

Earnings Preview: Assertio (ASRT) Q2 Earnings Expected to Decline

Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right Now?
KPTI

Insider Monkey

4 months ago

Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right Now?

Karyopharm Therapeutics Inc. (KPTI): Is This Penny Stock A Good Buy Right Now?
KPTI

Insider Monkey

4 months ago

Karyopharm Therapeutics Inc. (KPTI): Is This Penny Stock A Good Buy Right Now?

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

5 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KPTI

MT Newswires

5 months ago

HC Wainwright Adjusts Price Target on Karyopharm Therapeutics to $7 From $8, Maintains Buy Rating

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

6 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
KPTI

PR Newswire

6 months ago

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates

Karyopharm to Participate at the Jefferies Global Healthcare Conference
KPTI

PR Newswire

6 months ago

Karyopharm to Participate at the Jefferies Global Healthcare Conference

Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
KPTI

Simply Wall St.

6 months ago

Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
KPTI

Insider Monkey

7 months ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript

KPTI

GuruFocus.com

7 months ago

Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

KPTI

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Karyopharm Therapeutics Inc Earnings Call

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
KPTI

Motley Fool

7 months ago

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript

Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
KPTI

PR Newswire

7 months ago

Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference

KPTI

GuruFocus.com

7 months ago

Karyopharm Therapeutics Reports Q1 2024 Financial Results: A Detailed Review

KPTI

Associated Press Finance

7 months ago

Karyopharm Therapeutics: Q1 Earnings Snapshot

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
KPTI

PR Newswire

7 months ago

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
KPTI

PR Newswire

7 months ago

Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029

Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
KPTI

PR Newswire

7 months ago

Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

7 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
KPTI

PR Newswire

7 months ago

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

8 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
KPTI

PR Newswire

9 months ago

Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences

Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...
KPTI

GuruFocus.com

9 months ago

Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

9 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript
KPTI

Insider Monkey

9 months ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript

KPTI

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Karyopharm Therapeutics Inc Earnings Call

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
KPTI

Motley Fool

9 months ago

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
KPTI

Zacks

9 months ago

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

KPTI

Associated Press Finance

9 months ago

Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
KPTI

PR Newswire

9 months ago

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
KPTI

InvestorPlace

9 months ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
KPTI

PR Newswire

9 months ago

Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
KPTI

Zacks

9 months ago

Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
KPTI

Zacks

9 months ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
KPTI

Zacks

9 months ago

Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know

Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though investors from three years ago are still down 90%
KPTI

Simply Wall St.

10 months ago

Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though investors from three years ago are still down 90%

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI

PR Newswire

10 months ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

A Closer Look At Planet Image International Limited's (NASDAQ:YIBO) Impressive ROE
KPTI

Simply Wall St.

10 months ago

A Closer Look At Planet Image International Limited's (NASDAQ:YIBO) Impressive ROE

Byline Bancorp Inc (BY) Reports Solid Growth in 2023 Earnings
KPTI

GuruFocus.com

10 months ago

Byline Bancorp Inc (BY) Reports Solid Growth in 2023 Earnings

Why Eagle Bancorp Montana, Inc. (EBMT) is a Top Dividend Stock for Your Portfolio
KPTI

Zacks

10 months ago

Why Eagle Bancorp Montana, Inc. (EBMT) is a Top Dividend Stock for Your Portfolio

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
KPTI

ACCESSWIRE

10 months ago

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
KPTI

Business Wire

10 months ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

KPTI

Associated Press Finance

10 months ago

Five Point: Q4 Earnings Snapshot

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results
KPTI

Business Wire

10 months ago

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results

7 Cyclical Penny Stocks Best Positioned for 2024
KPTI

InvestorPlace

10 months ago

7 Cyclical Penny Stocks Best Positioned for 2024

KPTI

Business Wire

10 months ago

Motorcar Parts of America Announces Senior Sales Executive Transition

MiX Telematics Sets Third Quarter Fiscal Year 2024 Conference Call for February 1, 2024, at 8:00 a.m. ET and 3:00 p.m. SAST
KPTI

Business Wire

10 months ago

MiX Telematics Sets Third Quarter Fiscal Year 2024 Conference Call for February 1, 2024, at 8:00 a.m. ET and 3:00 p.m. SAST

3 Undiscovered Small-Cap Stocks to Snap Up Before They Soar
KPTI

InvestorPlace

10 months ago

3 Undiscovered Small-Cap Stocks to Snap Up Before They Soar

Is Flexsteel Industries (FLXS) Stock Outpacing Its Consumer Discretionary Peers This Year?
KPTI

Zacks

10 months ago

Is Flexsteel Industries (FLXS) Stock Outpacing Its Consumer Discretionary Peers This Year?

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
KPTI

GlobeNewswire

10 months ago

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

The 3 Best EV Charging Stocks to Buy in January 2024
KPTI

InvestorPlace

a year ago

The 3 Best EV Charging Stocks to Buy in January 2024

Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
KPTI

PR Newswire

a year ago

Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives

So-Young Announces Update on Repurchase and Cancellation of Shares
KPTI

PR Newswire

a year ago

So-Young Announces Update on Repurchase and Cancellation of Shares

Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update
KPTI

GlobeNewswire

a year ago

Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

LifeMD, Inc. (NASDAQ:LFMD) Shares Could Be 32% Above Their Intrinsic Value Estimate
KPTI

Simply Wall St.

a year ago

LifeMD, Inc. (NASDAQ:LFMD) Shares Could Be 32% Above Their Intrinsic Value Estimate

KPTI

Business Wire

a year ago

Special Opportunities Fund Declares Distributions For First Quarter of 2024

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
KPTI

PR Newswire

a year ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Noventiq and Corner Growth Acquisition Corp. File Form F-4 Ahead of Proposed Nasdaq Listing
KPTI

Business Wire

a year ago

Noventiq and Corner Growth Acquisition Corp. File Form F-4 Ahead of Proposed Nasdaq Listing

GigCapital5, Inc. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement
KPTI

Business Wire

a year ago

GigCapital5, Inc. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement

High Tide to Open First Canna Cabana in Mississauga, Ontario
KPTI

CNW Group

a year ago

High Tide to Open First Canna Cabana in Mississauga, Ontario

Is Expedia Group (EXPE) Stock Undervalued Right Now?
KPTI

Zacks

a year ago

Is Expedia Group (EXPE) Stock Undervalued Right Now?

Motorcar Parts of America, Inc. (NASDAQ:MPAA) is favoured by institutional owners who hold 70% of the company
KPTI

Simply Wall St.

a year ago

Motorcar Parts of America, Inc. (NASDAQ:MPAA) is favoured by institutional owners who hold 70% of the company

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions
KPTI

Business Wire

a year ago

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions

Comtech Telecommunications First Quarter 2024 Earnings: EPS Misses Expectations
KPTI

Simply Wall St.

a year ago

Comtech Telecommunications First Quarter 2024 Earnings: EPS Misses Expectations

Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)
KPTI

PR Newswire

a year ago

Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)

KPTI

Business Wire

a year ago

Special Opportunities Fund, Inc. Dividend Declaration

Great week for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) institutional investors after losing 84% over the previous year
KPTI

Simply Wall St.

a year ago

Great week for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) institutional investors after losing 84% over the previous year

KPTI

PR Newswire

a year ago

X Financial Reports Third Quarter 2023 Unaudited Financial Results

Share on Social Networks: